Zevra Therapeutics's total assets for Q3 2025 were $270.12M, an increase of 5.40% from the previous quarter. ZVRA total liabilities were $136.95M for the fiscal quarter, a -1.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.